Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer (NSCLC)
Melanoma (Skin Cancer)
Triple Negative Breast Cancer (TNBC)
RCC, Renal Cell Cancer
HNSCC

Interventions

OTHER: Blood sample collection

Sponsor

OncoHost Ltd.

Collaborators

[object Object]
[object Object]
[object Object]